Mutations of the p53-related protein kinase (PRPK) and TP53RK-binding protein (TPRKB) cause Galloway-Mowat syndrome (GAMOS) and are found in various human cancers. We have previously shown that small compounds targeting PRPK showed anti-cancer activity against colon and skin cancer. Here we present the 2.53 Å crystal structure of the human PRPK-TPRKB-AMPPNP (adenylyl-imidodiphosphate) complex. The structure reveals details in PRPK-AMPPNP coordination and PRPK-TPRKB interaction. PRPK appears in an active conformation, albeit lacking the conventional kinase activation loop. We constructed a structural model of the human EKC/KEOPS complex, composed of PRPK, TPRKB, OSGEP, LAGE3, and GON7. Disease mutations in PRPK and TPRKB are mapped into the structure, and we show that one mutation, PRPK K238Nfs*2, lost the binding to OSGEP. Our structure also makes the virtual screening possible and paves the way for more rational drug design.
M
A
A
A
R
A
T
T
P
A
D
G
E
E
P
A
P
E
A
E
A
L
A
A
A
R
E
R
S
S
R
F
L
S
G
L
E
L
V
K
Q
G
A
E
A
R
V
F
R
G
R
F
Q
G
R
A
A
V
I
K
H
R
F
P
K
G
Y
R
H
P
A
L
E
A
R
L
G
R
R
R
T
V
Q
E
A
R
A
L
L
R
C
R
R
A
G
I
S
A
P
V
V
F
F
V
D
Y
A
S
N
C
L
Y
M
E
E
I
E
G
S
V
T
V
R
D
Y
I
Q
S
T
M
E
T
E
K
T
P
Q
G
L
S
N
L
A
K
T
I
G
Q
V
L
A
R
M
H
D
E
D
L
I
H
G
D
L
T
T
S
N
M
L
L
K
P
P
L
E
Q
L
N
I
V
L
I
D
F
G
L
S
F
I
S
A
L
P
E
D
K
G
V
D
L
Y
V
L
E
K
A
F
L
S
T
H
P
N
T
E
T
V
F
E
A
F
L
K
S
Y
S
T
S
S
K
K
A
R
P
V
L
K
K
L
D
E
V
R
L
R
G
R
K
R
S
M
V
G